Results 101 to 110 of about 151,127 (351)

Prostatectomy [PDF]

open access: yesTransactions of the Royal Academy of Medicine in Ireland, 1892
n ...
openaire   +1 more source

Feasibility of Robotic Rectal Surgery Using the Hinotori Surgical Robot System

open access: yesWorld Journal of Surgery, EarlyView.
Patients' characteristics in hinotori and dV cases.
Hideya Kashihara   +6 more
wiley   +1 more source

Silodosin inhibits noradrenaline-activated transcription factors Elk1 and SRF in human prostate smooth muscle. [PDF]

open access: yes, 2012
The transcription factors Elk1 and serum response factor (SRF) are central regulators of cell cycle and phenotype in various cell types. Elk1 is activated by phosphorylation (serine-383), while activation of SRF requires its co-factor, myocardin ...
Andersson, Karl-Erik   +10 more
core   +2 more sources

Post‐prostatectomy chylous ascites treated by intranodal lymphangiography: A case report and review

open access: yesSurgical Practice, EarlyView.
Abstract Chylous ascites is a rare but significant complication following extended pelvic lymph node dissection (ePLND) during radical prostatectomy. No universal treatment guideline currently exists. Herein, we present the case of a 74‐year‐old patient with prostate cancer who developed chylous ascites after radical prostatectomy with bilateral ePLND.
Kin‐Yuan Ko   +4 more
wiley   +1 more source

Post‐Therapeutic Dosimetry of Metastatic Castration‐Resistant Prostate Cancer With 177Lu‐PSMA: Experiences From Two University‐Based Hospitals in Thailand

open access: yesAsia-Pacific Journal of Clinical Oncology, EarlyView.
ABSTRACT Objective 177Lu‐PSMA radioligand therapy (RLT) is increasingly used to treat metastatic castration‐resistant prostate cancer (mCRPC). Posttreatment dosimetry is essential for assessing normal organ absorbed doses. Therefore, this study aims to evaluate normal organs dosimetry in mCRPC patients undergoing 177Lu‐PSMA‐RLT from two university ...
Onnicha Pattanawong   +6 more
wiley   +1 more source

Genomic biomarkers in prostate cancer. [PDF]

open access: yes, 2018
Prostate cancer is the most common non-cutaneous cancer among men in the United States. In the last decade there has been a rapid expansion in the field of biomarker assays for diagnosis, prognosis, and treatment prediction in prostate cancer.
Cooperberg, Matthew R   +3 more
core  

Comparative efficacy of combination therapy including regenerative therapies versus monotherapy for erectile dysfunction: A systematic review and meta‐analysis

open access: yesAndrology, EarlyView.
Abstract Background and objective The Current European Association of Urology guidelines do not provide recommendation for combination of regenerative therapies with standard therapies for erectile dysfunction. The aim of this study was to compare the efficacy of combined regenerative therapy with monotherapy for erectile dysfunction.
Alberto Quistini   +12 more
wiley   +1 more source

A DWI-based hypoxia model shows robustness in an external prostatectomy cohort

open access: yesFrontiers in Oncology
IntroductionProstate cancer hypoxia is a negative prognostic biomarker. A promising MRI-based tool to assess hypoxia is the ‘Consumption and Supply based Hypoxia’ (CSH) model based on diffusion-weighted imaging (DWI). The aim of the study was to validate
M. Fernandez Salamanca   +12 more
doaj   +1 more source

The value of cystography in the prediction of early urinary continence after radical prostatectomy

open access: yesUrological Science, 2016
Objective: To determine the association between vesicourethral anastomosis level (VUAL) and the condition of the bladder neck with early recovery of urinary continence on cystography after radical prostatectomy.
Yi-Huei Chang   +6 more
doaj   +1 more source

Remote Follow‐Up After Colorectal Cancer Surgery: A Systematic Review

open access: yesANZ Journal of Surgery, EarlyView.
This systematic review investigated the impact of remote follow‐up in colorectal cancer on patient satisfaction and other indicators. Seven studies were included, which showed high levels of patient satisfaction. Further studies are needed to determine the effect on oncological outcomes.
Gajan Srikumar   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy